Pharmacological blockage of serotonin biosynthesis and circadian changes in oxaliplatin toxicity in rats

被引:6
作者
Boughattas, NA [1 ]
Ben Attia, M
Ixart, G
Lemaigre, G
Mechkouri, M
Reinberg, A
机构
[1] Fac Med, Pharmacol Lab, Monastir 5019, Tunisia
[2] Hop Paul Brousse, Lab Rythmes Biol & Chronotherapeut, F-94800 Villejuif, France
[3] Fac Sci Bizerte, Dept Sci Vie, Zarzouna 7021, Tunisia
[4] Univ Montpellier 2 USTL, CNRS, U97, Lab Neurobiol Endocrinol, F-34095 Montpellier 05, France
[5] Hop Antoine Beclere, Anat Pathol Lab, Clamart 92, France
[6] Fdn A de Rothschild, Unite Chronobiol, F-75940 Paris 19, France
关键词
chronopharmacology; chronotoxicology; circadian rhythm; oxaliplatin toxicity; para-chlorophenylalanine; serotoninergic system; suprachiasmatic nuclei;
D O I
10.1081/CBI-120015957
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study investigates if the serotoninergic system plays a role in chronotoxic effects of the anticancer agent oxaliplatin (l-OHP). Four groups of female rats (120 in total) synchronized with light-dark (12h:12h) were treated with: (i) saline, (ii) para-chlorophenylalanine (pCPA, an inhibitor of serotonin biosynthesis: 300 mg/kg/d, i.p. for two consecutive days), (iii) l-OHP (23 mg/kg, i.v.) at three different dosing times, or (iv) both pCPA and l-OHP. The results show pCPA (iii) obliterates the circadian rhythm in plasma ACTH but not in corticosterone or leukocytes, and (iii) l-OHP exerts circadian time-dependent toxic effects (body weight loss, leukopenia, and intestinal lesions) with greatest toxicity coinciding with treatment at the end of the nocturnal activity span (P<0.05). In rats whose serotonin biosynthesis was blocked (iv), the circadian rhythms in the toxic effects of l-OHP and in ACTH were obliterated, while the rhythms in corticosterone and leukocytes persisted.
引用
收藏
页码:1121 / 1136
页数:16
相关论文
共 30 条
[11]   Chronotherapy of colorectal cancer [J].
Giacchetti, S .
CHRONOBIOLOGY INTERNATIONAL, 2002, 19 (01) :207-219
[12]   Tumor-based rhythms of anticancer efficacy in experimental models [J].
Granda, TG ;
Lévi, F .
CHRONOBIOLOGY INTERNATIONAL, 2002, 19 (01) :21-41
[13]  
IXART G, 1985, NEUROENDOCRINOL LETT, V7, P171
[14]   Circadian chemotherapy for gynecological and genitourinary cancers [J].
Kobayashi, M ;
Wood, PA ;
Hrushesky, WJM .
CHRONOBIOLOGY INTERNATIONAL, 2002, 19 (01) :237-251
[15]  
Levi F, 1996, PATHOL BIOL, V44, P631
[16]   Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer [J].
Levi, F ;
Zidani, R ;
Misset, JL .
LANCET, 1997, 350 (9079) :681-686
[17]   From circadian rhythms to cancer chronotherapeutics [J].
Lévi, F .
CHRONOBIOLOGY INTERNATIONAL, 2002, 19 (01) :1-19
[18]   CIRCADIAN TIME-DEPENDENCE OF MURINE TOLERANCE FOR THE ALKYLATING AGENT PEPTICHEMIO [J].
LEVI, F ;
HORVATH, C ;
MECHKOURI, M ;
ROULON, A ;
BAILLEUL, F ;
LEMAIGRE, G ;
REINBERG, A ;
MATHE, G .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05) :487-&
[19]  
LEVI FA, 1982, CANCER RES, V42, P950
[20]   LETHAL NEPHROTOXICITY AND HEMATOLOGIC TOXICITY OF CIS-DIAMMINEDICHLOROPLATINUM AMELIORATED BY OPTIMAL CIRCADIAN TIMING AND HYDRATION [J].
LEVI, FA ;
HRUSHESKY, WJM ;
HALBERG, F ;
LANGEVIN, TR ;
HAUS, E ;
KENNEDY, BJ .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (05) :471-477